Price
Target price
€16.20
€16.20
-1.240%
-0.2
-1.240%
€33.46
22.08.24 / Tradegate
WKN: A2AF74 / Symbol: HCM / Name: Chi-Med / Stock / Pharmaceuticals / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Hutchison China MediTech Ltd ADR Stock
We can see a decrease in the price for Hutchison China MediTech Ltd ADR. Compared to yesterday it has lost -€0.200 (-1.240%).
Currently there is a rather positive sentiment for Hutchison China MediTech Ltd ADR with 4 Buy predictions and 0 Sell predictions.
Based on the current price of 16.2 € the target price of 33 € shows a potential of 103.7% for Hutchison China MediTech Ltd ADR which would more than double the current price.
Pros and Cons of Hutchison China MediTech Ltd ADR in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Hutchison China MediTech Ltd ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Hutchison China MediTech Ltd ADR | -1.240% | -3.571% | -12.903% | 27.559% | 2.532% | -54.237% | - |
| China Resources Pharmaceutical Group Ltd | -0.800% | -5.344% | -1.587% | 0.000% | 6.897% | 51.961% | -34.558% |
| China Traditional Chinese Medicine Co Ltd | -1.720% | -2.146% | 16.327% | 34.911% | 3.167% | 11.765% | 4.062% |
| Opko Health Inc. | 1.070% | 3.890% | 10.379% | -12.884% | 0.445% | -54.997% | -18.713% |
Comments
HUTCHMED (China) Limited (NASDAQ: HCM) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for HCM provided by MarketBeat
HUTCHMED (China) Limited (NASDAQ: HCM) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Show more
Ratings data for HCM provided by MarketBeat
HUTCHMED (China) Limited (NASDAQ: HCM) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating. They now have a $22.10 price target on the stock.
Show more
Ratings data for HCM provided by MarketBeat